181
Views
8
CrossRef citations to date
0
Altmetric
Review

Riding (High) into the danger zone: a review of potential differences in chemical exposures in fighter pilots resulting from high altitude and G-forces

, , , , , & show all
Pages 925-934 | Received 22 Apr 2016, Accepted 25 Jul 2017, Published online: 20 Aug 2017

References

  • SAB. United States Air Force scientific advisory board report on aircraft oxygen generation. In: USAF, ed. 2012. Available from: http://www.airforcemag.com/DocumentFile/Documents/2012/AFSAB_Oxygen_020112.pdf
  • F-22 Pilot Physiological Issues. 2012. Subcommittee on tactical air and land forces of the committee on armed services. 2 ed. Available from: https://www.gpo.gov/fdsys/pkg/CHRG-112hhrg76215/html/CHRG-112hhrg76215.htm
  • Clark JD. Isopropyl alcohol intoxication. J Emerg Nurs. 2010 Jan;36(1):81–82.
  • Slaughter RJ, Mason RW, Beasley DM, et al. Isopropanol poisoning. Clin Toxicol (Phila). 2014 Jun;52(5):470–478.
  • Zaman F, Pervez A, Abreo K. Isopropyl alcohol intoxication: a diagnostic challenge. Am J Kidney Dis. 2002 Sep;40(3:E12.
  • (OSHA) USDoLOSHA. Isopropyl Alcohol. [ cited 2015 Dec 8]. Available from: https://www.osha.gov/dts/chemicalsampling/data/CH_248400.html
  • Jammalamadaka D, Raissi S. Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 2010 Mar;339(3):276–281.
  • Vujasinovic M, Kocar M, Kramer K, et al. Poisoning with 1-propanol and 2-propanol. Hum Exp Toxicol. 2007 Dec;26(12):975–978.
  • Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008 Jan;3(1):208–225.
  • Blow BJ, Ge Y, Safdar Z. Respiratory failure, lung infiltrates, and hemoptysis in a woman with chronic isopropyl alcohol inhalation. Ther Adv Respir Dis. 2012 Jun;6(3):189–193.
  • Burleigh-Flayer H, Garman R, Neptun D, et al. Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol. 1997 Apr;36(2):95–111.
  • Burleigh-Flayer H, Gill M, Hurley J, et al. Motor activity effects in female Fischer 344 rats exposed to isopropanol for 90 days. J Appl Toxicol. 1998 Sep-Oct;18(5):373–381.
  • Merritt BA, Okyere CP, Jasinski DM. Isopropyl alcohol inhalation: alternative treatment of postoperative nausea and vomiting. Nurs Res. 2002 Mar-Apr;51(2):125–128.
  • Dalziel K, Dickinson FM. The kinetics and mechanism of liver alcohol dehydrogenase with primary and secondary alcohols as substrates. Biochem J. 1966 Jul;100(1):34–46.
  • Brugnone F, Perbellini L, Apostoli P, et al. Isopropanol exposure: environmental and biological monitoring in a printing works. Br J Ind Med. 1983 May;40(2):160–168.
  • Blanchet B, Charachon A, Lukat S, et al. A case of mixed intoxication with isopropyl alcohol and propanol-1 after ingestion of a topical antiseptic solution. Clin Toxicol (Phila). 2007 Sep;45(6):701–704.
  • Mydler TT, Wasserman GS, Watson WA, et al. Two-week-old infant with isopropanol intoxication. Pediatr Emerg Care. 1993 Jun;9(3):146–148.
  • Dua SL. Letter: peritoneal dialysis for isopropyl alcohol poisoning. JAMA. 1974 Oct 7;230(1):35.
  • Ernstgard L, Sjogren B, Warholm M, et al. Sex differences in the toxicokinetics of inhaled solvent vapors in humans 2. 2-propanol. Toxicol Appl Pharmacol. 2003 Dec 1;193(2):158–167.
  • Vivier PM, Lewander WJ, Martin HF, et al. Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emerg Care. 1994 Apr;10(2):91–93.
  • Daniel DR, McAnalley BH, Garriott JC. Isopropyl alcohol metabolism after acute intoxication in humans. J Anal Toxicol. 1981 May-Jun;5(3):110–112.
  • Natowicz M, Donahue J, Gorman L, et al. Pharmacokinetic analysis of a case of isopropanol intoxication. Clin Chem. 1985 Feb;31(2):326–328.
  • Gaudet MP, Fraser GL. Isopropanol ingestion: case report with pharmacokinetic analysis. Am J Emerg Med. 1989 May;7(3):297–299.
  • Lacouture PG, Heldreth DD, Shannon M, et al. The generation of acetonemia/acetonuria following ingestion of a subtoxic dose of isopropyl alcohol. Am J Emerg Med. 1989 Jan;7(1):38–40.
  • Parker KM, Lera TA Jr. Acute isopropanol ingestion: pharmacokinetic parameters in the infant. Am J Emerg Med. 1992 Nov;10(6):542–544.
  • Jones AW. Elimination half-life of acetone in humans: case reports and review of the literature. J Anal Toxicol. 2000 Jan-Feb;24(1):8–10.
  • Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5–13.
  • Lee SL, Shih HT, Chi YC, et al. Oxidation of methanol, ethylene glycol, and isopropanol with human alcohol dehydrogenases and the inhibition by ethanol and 4-methylpyrazole. Chem Biol Interact. 2011 May 30;191(1–3):26–31.
  • Clewell HJ 3rd, Gentry PR, Gearhart JM, et al. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci. 2001 Oct;63(2):160–172.
  • Gentry PR, Covington TR, Andersen ME, et al. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol. 2002 Aug;36(1):51–68.
  • Huizer D, Oldenkamp R, Ragas AM, et al. Separating uncertainty and physiological variability in human PBPK modelling: the example of 2-propanol and its metabolite acetone. Toxicol Lett. 2012 Oct 17;214(2):154–165.
  • Huizer D, Huijbregts MA, Van Rooij JG, et al. Testing the coherence between occupational exposure limits for inhalation and their biological limit values with a generalized PBPK-model: the case of 2-propanol and acetone. Regul Toxicol Pharmacol. 2014 Aug;69(3):408–415.
  • Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev. 1974 Jan;54(1):75–159.
  • Ciccone CD. Basic pharmacokinetics and the potential effect of physical therapy interventions on pharmacokinetic variables. Phys Ther. 1995 May;75(5):343–351.
  • Peng HT, Cheung B. A review of psychophysiological stressors on pharmacokinetics. J Clin Pharmacol. 2011 Nov;51(11):1499–1518.
  • Graebe A, Schuck EL, Lensing P, et al. Physiological, pharmacokinetic, and pharmacodynamic changes in space. J Clin Pharmacol. 2004 Aug;44(8):837–853.
  • Olsson B, Bondesson E, Borgstrom L, et al. Pulmonary drug metabolism, clearance, and absorption. In: Smyth HDC, Hickey AJ, editors. Controlled pulmonary drug delivery.Controlled Release Society; Newyork:Springer. 2011.
  • Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation. 2007 Nov 6;116(19):2191–2202.
  • Higgins EA, Vaughan JA, Funkhouser GE. Blood alcohol concentrations as affected by combinations of alcoholic beverage dosages and altitudes. In: Transportation Do, ed. 1970. Washington, DC:Department of Transportation, Federal Aviation Administration, Office of Aviation Medicine. Available from: http://libraryonline.erau.edu/online-full-text/faa-aviation-medicine-reports/AM70-05.pdf
  • Higgins EA, Davis AW Jr., Vaughan JA, et al. The effects of alcohol at three simulated aircraft cabin conditions. In: Transportation Do, ed. 1968. Washington, DC:Department of Transportation, Federal Aviation Administration, Office of Aviation Medicine. Available from: http://libraryonline.erau.edu/online-full-text/faa-aviation-medicine-reports/AM68-18.pdf
  • Collins WE, Mertens HW, Higgins EA. Some effects of alcohol and simulated altitude on complex performance scores and breathalyzer readings. In: Transportation Do, ed. 1985.Washington, DC:US Department of Transportation, Federal Aviation Administration, Office of Aviation Medicine. Available from: https://www.faa.gov/data_research/research/med_humanfacs/oamtechreports/1980s/media/AM85-05.pdf
  • Collins WE, Mertens HW. Age, alcohol, and simulated altitude: effects on performance and breathalyzer scores. In: Transportation Do, ed. 1988.Washington, DC:US Department of Transportation, Federal Aviation Administration, Office of Aviation Medicine. Available from: https://www.faa.gov/data_research/research/med_humanfacs/oamtechreports/1980s/media/AM88-02.pdf
  • Modell JG, Mountz JM. Drinking and flying–the problem of alcohol use by pilots. N Engl J Med. 1990 Aug 16;323(7):455–461.
  • Fowles R, Loeb PD. The interactive effect of alcohol and altitude on traffic fatalities. South Econ J. 1992;59(1):108–112.
  • Roeggla G, Roeggla H, Roeggla M, et al. Effect of alcohol on acute ventilatory adaptation to mild hypoxia at moderate altitude. Ann Intern Med. 1995 Jun 15;122(12):925–927.
  • Ritschel WA, Paulos C, Arancibia A, et al. Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude. J Clin Pharmacol. 1998 Jun;38(6):533–539.
  • Li XY, Gao F, Li ZQ, et al. Comparison of the pharmacokinetics of sulfamethoxazole in male Chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: an open-label, controlled, prospective study. Clin Ther. 2009 Nov;31(11):2744–2754.
  • Li W, Wang R, Xie H, et al. Changes of pathological and physiological indicators affecting drug metabolism in rats after acute exposure to high altitude. Exp Ther Med. 2015 Jan;9(1):98–104.
  • Wyrick B, Brown JR. Acceleration in aviation: G-force. In: Administration FA, ed. Oklahoma City, OK:FAA Civil Aerospace Medical Institute. 2009.  Available from: https://www.faa.gov/pilots/safety/pilotsafetybrochures/media/Acceleration.pdf
  • Newman DG, Callister R. Analysis of the Gz environment during air combat maneuvering in the F/A-18 fighter aircraft. Aviat Space Environ Med. 1999 Apr;70(4):310–315.
  • Srinivasan RS, Bourne DW, Putcha L. Application of physiologically based pharmacokinetic models for assessing drug disposition in space. J Clin Pharmacol. 1994 Jun;34(6):692–698.
  • Schuck EL, Grant M, Derendorf H. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. J Clin Pharmacol. 2005 Jul;45(7):822–831.
  • Sieber M, Hanke W, Kohn FPM. Modification of membrane fluidity by gravity. Open J Biophys. 2014;4:105–111.
  • Dos Santos MA, Bosquillon C, Russoman T, et al. Modelling the effects of microgravity on the permeability of air interface respiratory epithelial cell layers. Adv Space Res. 2010;46:712–718.
  • Goldermann M, Hanke W. Ion channel are sensitive to gravity changes. Microgravity Sci Technol. 2001;13(1):35–38.
  • Habazettl H, Stahn A, Nitsche A, et al. Microvascular responses to (hyper-)gravitational stress by short-arm human centrifuge: arteriolar vasoconstriction and venous pooling. Eur J Appl Physiol. 2016 Jan;116(1):57–65.
  • Newman DG, Callister R. Cardiovascular training effects in fighter pilots induced by occupational high G exposure. Aviat Space Environ Med. 2008 Aug;79(8):774–778.
  • Scott JP, Jungius J, Connolly D, et al. Subjective and objective measures of relaxed +Gz tolerance following repeated +Gz exposure. Aviat Space Environ Med. 2013 Jul;84(7):684–691.
  • Lalande S, Buick F. Physiologic +Gz tolerance responses over successive +Gz exposures in simulated air combat maneuvers. Aviat Space Environ Med. 2009 Dec;80(12):1032–1038.
  • Darquenne C, Paiva M, West JB, et al. Effect of microgravity and hypergravity on deposition of 0.5- to 3-micron-diameter aerosol in the human lung. J Appl Physiol (1985). 1997 Dec;83(6):2029–2036.
  • Kim H-S, Kim YW. Hypergravity induces overexpression of inducible nitric oxide synthase in mouse livers. J Anim Vet Adv. 2013;12(1):34–37.
  • Kim HS, Jung YY, Do SI. Hepatic inducible nitric oxide synthase expression increases upon exposure to hypergravity. Braz J Med Biol Res. 2014 Nov;47(11):940–946.
  • Newman D. How much is too much? Flight Safety Australia; 1999;43–44.
  • Burton RR, Jaggars JL. Influence of ethyl alcohol ingestion on a target task during sustained +Gz centrifugation. Aerosp Med. 1974 Mar;45(3):290–296.
  • Morrissette KL, McGowan DG. Further support for the concept of a G-LOC syndrome: a survey of military high-performance aviators. Aviat Space Environ Med. 2000 May;71(5):496–500.
  • Rickards CA, Newman DG. G-induced visual and cognitive disturbances in a survey of 65 operational fighter pilots. Aviat Space Environ Med. 2005 May;76(5):496–500.
  • Shender BS, Forster EM, Hrebien L, et al. Acceleration-induced near-loss of consciousness: the “A-LOC” syndrome. Aviat Space Environ Med. 2003 Oct;74(10):1021–1028.
  • Newman D. Alcohol and human performance from an aviation perspective: a review. In:Bureau ATS, ed. 2004.
  • Ross LE, Mughni WN. Effect of alcohol on the threshold for detecting angular acceleration. Aviat Space Environ Med. Canberra, Australia:Australian Transport Safety Bureau. 1995 Jul;66(7):635–640.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.